Our company SULFOBUTYL ETHER BETA CYCLODEXTRIN SODIUM CAS182410-00-0 and HYDROXYPROPYL-BETA-CYCLODEXTRIN CAS 128446-35-5/94035-02-6 have reached the injection grade.
SULFOBUTYL ETHER BETA CYCLODEXTRIN SODIUM is a new type of anionic highly water-soluble cyclodextrin derivative, which can be well incorporated with drug molecules to form non-covalent complexes, thereby improving the stability, water solubility and safety of the drug It can reduce nephrotoxicity, ease drug hemolysis, control drug release rate, and mask bad odors.
At present, it has been applied to injection medicine, oral medicine, nasal medicine, eye medicine, and has special affinity and compatibility for nitrogen-containing medicines.
HYDROXYPROPYL-BETA-CYCLODEXTRIN can be used as a solubilizer, embedding agent, stabilizer, etc. It can solve the water solubility problem of insoluble or poorly soluble drugs (including plant extracts). Through molecular embedding, the biosolubility of the drug is improved and the drug release rate is controlled, the bioavailability of the drug is improved, the stability of the drug is enhanced, the bioavailability of the drug is reduced, the stability of the drug is enhanced, and the toxic and side effects of the drug are reduced.